Cardiovascular diseases (CVDs) remain the leading cause of health problems worldwide.
Nanotechnology, based on its unique properties, provides novel solutions to the diagnosis …

Cardiovascular diseases (CVDs) pose a serious threat to human life and health. The rapid
diagnosis and evaluation of CVDs have become a vital topic in protecting life and health …

Acute myocardial infarction (AMI) is a significant health problem owing to its high mortality
rate. Heart-type fatty acid–binding protein (h-FABP) is an important biomarker in the …

Heart-type fatty acid binding protein (H-FABP) has been regarded as a promising biomarker
for early diagnosis of acute myocardial infarction (AMI). Developing fast and reliable method …

In this work, a novel ECL immunosensor based on self-enhanced luminophore and ultrathin
2D nickel MOF nanosheets was fabricated for sensitive and specific detection of h-FABP …

The detection of cardiac biomarkers is used for diagnostics, prognostics, and the risk
assessment of cardiovascular diseases. The analysis of cardiac biomarkers is routinely …

With its complicated pathophysiology, high incidence and prevalence, heart failure remains
a major public concern. In hopes of improving diagnosis, treatment and prognosis, the utility …

The aim of this narrative review is to summarize contemporary evidence on the use of
circulating cardiac biomarkers of heart failure (HF) and to identify a promising biomarker …

Acute myocardial infarction (AMI) is a cardiovascular disease that is produced due to a
deficiency of oxygen generating irreversible damage in the heart muscle. In diagnosis …

Heart-type fatty acid binding protein (H-FABP) is an early biomarker for acute myocardial
infarction. The concentration of H-FABP in circulation sharply increases during myocardial …